Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies

VL Feigin, GJE Rinkel, CMM Lawes, A Algra… - Stroke, 2005 - Am Heart Assoc
Background and Purpose— After a 1996 review from our group on risk factors for subarachnoid
hemorrhage (SAH), much new information has become available. This article provides …

Calcium antagonists for aneurysmal subarachnoid haemorrhage

S Dorhout Mees, GJE Rinkel, VL Feigin… - Cochrane database …, 1996 - cochranelibrary.com
Background Secondary ischaemia is a frequent cause of poor outcome in patients with
subarachnoid haemorrhage. Its pathogenesis has not been elucidated yet, but may be related to …

Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis

MJH Wermer, IC van der Schaaf, A Algra, GJE Rinkel - Stroke, 2007 - Am Heart Assoc
… 2 Brilstra EH, Rinkel GJE, van der Graaf Y, van Rooij WJ, Algra A. Treatment of intracranial
… 3 Raaymakers TW, Rinkel GJE, Limburg M, Algra A. Mortality and morbidity of surgery for …

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

PH Halkes, J Van Gijn, LJ Kappelle… - Lancet (London …, 2006 - europepmc.org
Background Results of trials of aspirin and dipyridamole combined versus aspirin alone for
the secondary prevention of vascular events after ischaemic stroke of presumed arterial …

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …

European stroke initiative recommendations for stroke management–update 2003

GE Carlsson, A Möller, C Blomstrand, T Ueda… - Cerebrovascular …, 2003 - karger.com
This article represents the update of ‘European Stroke Initiative Recommendations for Stroke
Management’, first published in this Journal in 2000. The recommendations are endorsed …

Second manifestations of ARTerial disease (SMART) study: rationale and design

PCG Simons, A Algra, MF Van De Laak… - European journal of …, 1999 - Springer
… Simons PCG, Graaf van der Y, Banga JD, Eikelboom BC, Algra A. Screening for asymptomatic
vascular disease and risk factors in high risk patients: Assessment of current practice. Ned …

The prognostic value of domain-specific cognitive abilities in acute first-ever stroke

GMS Nys, MJE Van Zandvoort, PLM De Kort… - Neurology, 2005 - AAN Enterprises
Objective: To evaluate the prognostic value of domain-specific cognitive abilities in acute
stroke with respect to long-term cognitive and functional outcome in addition to neurologic and …

Endovascular therapy for stroke due to basilar-artery occlusion

LCM Langezaal, EJRJ Van Der Hoeven… - … England Journal of …, 2021 - Mass Medical Soc
Background The effectiveness of endovascular therapy in patients with stroke caused by
basilar-artery occlusion has not been well studied. Methods We randomly assigned patients …

Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes

SM Manschot, AMA Brands, J van der Grond… - Diabetes, 2006 - Am Diabetes Assoc
The structural correlates of impaired cognition in type 2 diabetes are unclear. The present
study compared cognition and brain magnetic resonance imaging (MRI) between type 2 …